Dotmatics Limited

Dotmatics Limited

February 17, 2012 09:03 ET

Dotmatics Licenses Its Informatics Suite to IRBM-Science Park

BISHOPS STORTFORD, UNITED KINGDOM--(Marketwire - Feb. 17, 2012) - Dotmatics, a provider of informatics tools and scientific data management solutions to the international pharmaceutical and biotechnology industries, is very pleased to announce that it has licensed its bioinformatics suite to IRBM Science Park, Rome, Italy. The solutions suite covers SAR analysis, chemical informatics, data capture, compound sourcing and biochemical data management. The solution will be used to register, query, browse, analyze and visualize information across multiple research programs and project teams.

Stephen Gallagher, Chief Executive Officer of Dotmatics said "Having had a fruitful working relationship with IRBM prior to its spin-off from Merck Sharpe & Dohme, it's a great pleasure to be able to continue to work with IRBM Science Park as they create an informatics platform optimized for the sites new business model."

Alberto Bresciani, Head of Screening Technologies at IRBM Science Park said "Our choice of the Dotmatics software suite was based on our need for a reliable but flexible chemoinformatics environment capable of addressing data management and data analysis across a set of highly diverse projects. We have found the flexibility and ease of use of the dotmatics tools to be perfectly aligned with our project teams needs, providing us with a unified platform from which to efficiently manage scientific data. The suite's tools for sharing information across the organization have been a huge success, and Dotmatics' support in customizing the software to our needs has been first rate. We are excited to be going forward with Dotmatics during this period of rapid expansion of IRBM Science Park's operations and information management needs.

About Dotmatics

By enabling discovery organizations to share and use their research information more efficiently, the company's aims are to facilitate the generation of strategic knowledge, making the right information available to the right person, at the right time and to boost customers' productivity by maximizing their information and knowledge awareness across the spectrum of their discovery activities.

Some product highlights:

Browser - web-based tool for querying, browsing and visualizing biological databases such as IDBS' ActivityBase and any chemical database.

Vortex - world-class visualization and analytics platform for scientific and non-scientific data.

Gateway - securely enables research teams to share information internally and with external partners.

Pinpoint - powerful Oracle chemical cartridge for querying and integrating chemical databases*. Pinpoint represents world-class indexing and search performance at a cost-effective price.

Register - flexible and scalable chemical registration system.

Nucleus - map and import biological and non-biological data files into an Oracle database.

Studies - the new standard in screening data management.

About IRBM Science Park

Created in October 2009 as a spin-off from Merck Research Laboratories' basic research site in Rome (Italy), IRBM Science Park provides a broad spectrum of research services for drug discovery, organic chemistry, and biomedical sciences. Backed by state-of-the-art facilities and decades of success in industrial drug discovery, IRBM Science Park provides world class custom services in chemistry, biochemistry, screening and both in-vitro & in-vivo pharmacology. IRBM Science Park additionally collaborates with major international pharmaceutical companies and research organizations toward the discovery of new small molecule and peptide therapeutics and biologics. In partnership with the Italian CNR (Consiglio Nazionale delle Ricerche) and ISS (Istituto Superiore di Sanita'), IRBM Science Park coordinates the Collezione Nazionale dei Composti Chimici e Centro di Screening (CNCCS). The aim of CNCCS is the formation of a centralized compound library and screening centre in Italy as a resource for the identification of novel biochemical targets and lead compounds. IRBM Science park additionally hosts a state of the art GMP (Good Manufacturing Practices) production facility that is run by Advent, a joint venture between IRBM Science Park and Okairos. This facility provides research grade and clinical grade recombinant adenoviral vectors for gene therapy and vaccine applications. For more information on IRBM Science Park see www.irbm.it.

* Developed in collaboration with Astex Therapeutics.

Contact Information

  • Enquiries: Dotmatics Limited Head Office
    The Old Monastery, Windhill
    Bishops Stortford, Herts, CM23 2ND, UK
    +44(0)1279 654 123
    +44(0)1279 653 088 (FAX)
    sales@dotmatics.com

    Dotmatics North America, West Coast
    11300 Sorrento Valley Road, Suite 115
    San Diego, CA 92121, USA
    +1 619 419 2808

    Dotmatics East Coast
    400 W Cummings Park, Suite 5450
    Woburn, MA 01801, USA
    +1 781 281 2330